Published in Int J Womens Dermatol on February 16, 2017
'Relaxers' damage hair: evidence from amino acid analysis. J Am Acad Dermatol (2010) 1.52
Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol (2002) 1.24
Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol (2010) 1.24
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol (2007) 1.17
Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol (1993) 1.16
The comparative histopathology of male-pattern baldness and senescent baldness. Clin Dermatol (1989) 1.14
Finasteride treatment of female pattern hair loss. Arch Dermatol (2006) 1.12
Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol (1992) 1.12
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol (2006) 1.12
Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol (1999) 0.98
Androgenetic alopecia in women. J Investig Dermatol Symp Proc (2003) 0.97
Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect. J Invest Dermatol (1997) 0.91
Ceramic flat irons: improper use leading to acquired trichorrhexis nodosa. J Am Acad Dermatol (2010) 0.90
The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res (2007) 0.88
Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol (2001) 0.88
What is your diagnosis? Bubble hair. Cutis (2008) 0.87
Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. J Investig Dermatol Symp Proc (1999) 0.87
Ketoconazole shampoo: effect of long-term use in androgenic alopecia. Dermatology (1998) 0.86
The hair follicle-stimulating properties of peptide copper complexes. Results in C3H mice. Ann N Y Acad Sci (1991) 0.85
Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results. J Am Acad Dermatol (2006) 0.85
Dutasteride improves male pattern hair loss in a randomized study in identical twins. J Cosmet Dermatol (2007) 0.82
Reversal of androgenetic alopecia by topical ketoconzole: relevance of anti-androgenic activity. J Dermatol Sci (2006) 0.80
Female pattern hair loss, sebum excretion and the end-organ response to androgens. Br J Dermatol (2006) 0.79
The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women. J Am Acad Dermatol (1999) 0.78
Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment. Dermatologica (1987) 0.77
Novel and established potassium channel openers stimulate hair growth in vitro: implications for their modes of action in hair follicles. J Invest Dermatol (2005) 0.77
Safety of topical minoxidil solution: a one-year, prospective, observational study. J Cutan Med Surg (2003) 0.77
Hair loss and hirsutism in the elderly. Clin Geriatr Med (2002) 0.77
Direct T-cell effects of minoxidil. Clin Dermatol (1989) 0.77
The hair cycle and its regulation. Clin Dermatol (1989) 0.76
What ages hair? Int J Womens Dermatol (2015) 0.75